Technology Advantage Emphasize Partillion's nanovial platform for rapid single-cell compartmentalization and analysis of secreted proteins, enabling high-throughput, scalable assays for antibody discovery and cell–cell interaction studies. Highlight validation through peer‑reviewed journals and industry awards to support credibility with biotech, pharma, and academic buyers.

Developer Kit Growth Promote the recently launched Developer Kits and Early Access Program as doors to collaboration with CROs, academic labs, and biotech startups seeking to build custom assays and workflows around Nanovials, offering co-development and faster adoption.

Credibility & Awards Leverage the platform’s award recognition and journal citations to mitigate adoption risk and justify ROI for potential customers in immune-oncology, antibody discovery, and high-throughput screening.

Market Momentum Align outreach with industry momentum around single-cell and cell-cell interaction analytics, citing participation in CYTO and Cell-Cell Symposium to position Partillion as a leader in cutting-edge analytics and a partner for large-scale experiments.

Regional Focus Target West Coast biotech clusters and academic labs near Los Angeles, offering scalable single-cell assay solutions to regional customers and potential channel partners, including CROs and academic consortia.